🇺🇸 FDA
Pipeline program

5% Lidocaine patch

LIG13-CN-301

Phase 3 small_molecule completed

Quick answer

5% Lidocaine patch for Herpes Zoster Pain is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Herpes Zoster Pain
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials